Lucas G Hill

Dr. Hill is devoted to addressing substance use challenges through community engaged research and innovative educational programs. He serves as Executive Director of the Program Evaluation and Research Unit (PERU), a team of more than 40 research staff with expertise in implementation science, data analysis, and professional education. Dr. Hill graduated from the University of Missouri–Kansas City School of Pharmacy, completed a family medicine pharmacy residency at UPMC St. Margaret, and completed a faculty development fellowship at the University of Pittsburgh School of Medicine. He founded the PhARM Program at The University of Texas at Austin and led several Texas Targeted Opioid Response projects focused on health professional education and community overdose prevention. Dr. Hill's current research focuses on identifying, exploring, and addressing gaps in pharmacy implementation of evidence-based substance use disorder treatment and harm reduction strategies. He serves on the board of directors of the Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) and on the editorial board of the Journal of the American College of Clinical Pharmacy (JACCP).

Research Expertise

• Substance Use Disorders
• Harm Reduction Strategies
• Opioid Stewardship Programs
• Clinical Pharmacy Services
• Continuing Professional Development